Brief: Mustang Bio Received Letter From Nasdaq Notifying Co Was Not In Compliance With Nasdaq Listing Rule 5550(B)(1)
15/03/2024 21:58
March 15 (Reuters) - Mustang Bio Inc MBIO.O :
* MUSTANG BIO INC- ON MARCH 13, RECEIVED LETTER FROM NASDAQ
NOTIFYING CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE
5550(B)(1)
Source text for Eikon: ID:n0001104659-24-035016
Further company coverage: MBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie